EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus

Mayalen Uthurriague iD, Estibaliz Lazaro iD, Christophe Richez iD, Patrick Blanco iD, Noémie Gensous iD

Expert Review of Clinical Pharmacology · 2025

DOI: 10.1080/17512433.2025.2573783 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2025. Verfasst von Mayalen Uthurriague und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Centre National de Référence des Maladies Auto-Immunes Systémiques Rares RESO, CHU de Bordeaux, Bordeaux, France. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Pregnancy Complications. Die Arbeit nennt 158 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Pregnancy in women with systemic lupus erythematosus presents significant clinical challenges due to heightened risks of complications for both mother and fetus. Therapeutic management must be carefully tailored to safeguard maternal health while ensuring optimal fetal development. AREAS COVERED: This review explores pharmacological treatments used during pregnancy in women with lupus, focusing on medication safety profiles, risk-benefit analyses of available therapeutic options, and specific challenges posed by comorbidities such as antiphospholipid syndrome and vaccination considerations. EXPERT OPINION: Although significant advances have been made in managing lupus during pregnancy, many treatments, particularly biologic therapies, still lack sufficient evidence for unrestricted use. This underscores the necessity for vigilant monitoring and individualized treatment protocols. Preconception consultation remains crucial for optimizing therapeutic strategies, ensuring appropriate medication adjustments prior to conception. A coordinated multidisciplinary approach is essential to navigate these complexities and achieve favorable outcomes for both mother and child.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicPregnancy ComplicationsHumansPregnancyFemaleAntiphospholipid SyndromeRisk AssessmentPreconception CareBiological Products

Stichwörter der Autor:innen

Antiphospholipid syndromefetal safetylupus erythematosus, systemicpregnancy complicationspregnancy managementreproductive healthteratogenicitytreatment planningtreatment safetywomen’s health

Substanzen

Biological Products

Autor:innen und Institutionen

  • Department of Rheumatology, Centre National de Référence des Maladies Auto-Immunes Systémiques Rares RESO, CHU de Bordeaux, Bordeaux, France.
  • UMR/CNRS 5164, immunoconcept, CNRS, University of Bordeaux, Bordeaux, France.
  • Department of Internal Medicine and Infectious Diseases, Centre National de Référence des Maladies Auto-Immunes Systémiques Rares RESO, CHU Bordeaux, Pessac, France.
  • Department of Immunology and Immunogenetics, CHU Bordeaux, Bordeaux, France.
  • Department of Internal Medicine and Clinical Immunology, CHU Bordeaux, Bordeaux, France.

ORCID-Profile: Mayalen Uthurriague, Estibaliz Lazaro, Christophe Richez, Patrick Blanco, Noémie Gensous

Zitieren

APA

Uthurriague, M., Lazaro, E., Richez, C., Blanco, P., & Gensous, N. (2025). Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2025.2573783

Vancouver

Uthurriague M, Lazaro E, Richez C, Blanco P, Gensous N. Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus. Expert Review of Clinical Pharmacology. 2025. doi:10.1080/17512433.2025.2573783

BibTeX
@article{Uthurriague2025,
  author = {Uthurriague, Mayalen and Lazaro, Estibaliz and Richez, Christophe and Blanco, Patrick and Gensous, Noémie},
  title = {Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2025},
  doi = {10.1080/17512433.2025.2573783}
}
Kostenlos starten →